A straightforward, reproducible, and scalable synthesis of CTet is reported, together with a formulation of CTet that allows the molecule to exert its pharmacological potential as an inhibitor of DNA synthesis in both ER+ and ER- human breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.